Crohn’s & Colitis Congress™
Tweet
Sessions
Speakers
Exhibitors
Floor Plan
Buzz
Search
Sessions
(339)
View/Sort by
Tracks
|
Day
Details
Perspectives: IBD Review for Professionals ($$)
(
Room
Bristlecone 3
)
18 Jan 18
8:00 AM
-
4:00 PM
Welcome and Introduction
(
Room
Bristlecone 3
)
18 Jan 18
8:00 AM
-
8:15 AM
Causes of IBD
(
Room
Bristlecone 3
)
18 Jan 18
8:15 AM
-
9:00 AM
A Clinician’s Guide to Fecal Microbiota Transplant (FMT) ($$)
(
Room
Bristlecone 2
)
18 Jan 18
8:30 AM
-
4:50 PM
Welcome and Introduction
(
Room
Bristlecone 2
)
18 Jan 18
8:30 AM
-
8:45 AM
Diagnosing Recurrent C. difficile Infection — Testing Strategies, Pitfalls and Differentiating rCDI From Post-Infectious IBS
(
Room
Bristlecone 2
)
18 Jan 18
8:45 AM
-
9:15 AM
Diagnosis and Prognosis of IBD — Latest Information
(
Room
Bristlecone 3
)
18 Jan 18
9:00 AM
-
9:45 AM
C. difficile Infection in IBD Patients and Current Status of FMT in This Population
(
Room
Bristlecone 2
)
18 Jan 18
9:15 AM
-
9:45 AM
Coffee Break
(
Room
Bristlecone 3
)
18 Jan 18
9:45 AM
-
10:00 AM
Fecal Donor Selection and Screening (Guideline Recommendations: European Consensus vs. ACG vs. IDSA-SHEA )
(
Room
Bristlecone 2
)
18 Jan 18
9:45 AM
-
10:15 AM
Medical and Surgical Management of IBD: UC
(
Room
Bristlecone 3
)
18 Jan 18
10:00 AM
-
11:00 AM
Best Practices in FMT — Administration, Formulation, Protocol
(
Room
Bristlecone 2
)
18 Jan 18
10:15 AM
-
10:45 AM
Coffee Break
18 Jan 18
10:45 AM
-
11:05 AM
Medical and Surgical Management of IBD: Crohn’s
(
Room
Bristlecone 3
)
18 Jan 18
11:00 AM
-
12:00 PM
Managing FMT Non-Responders and Adverse Events
(
Room
Bristlecone 2
)
18 Jan 18
11:05 AM
-
11:35 AM
What Happens to the Gut Microbiome Post-FMT?
(
Room
Bristlecone 2
)
18 Jan 18
11:35 AM
-
12:05 PM
Lunch and Networking Break
(
Room
Bristlecone 2
)
18 Jan 18
12:05 PM
-
1:05 PM
Cutting-Edge Pediatric IBD ($$)
(
Room
Bristlecone 4
)
18 Jan 18
1:00 PM
-
5:00 PM
Introduction and Lloyd Mayer Award Ceremony
(
Room
Pinyon 3
)
18 Jan 18
1:00 PM
-
1:05 PM
Managing IBD for Optimal Patient Care ($$)
(
Room
Pinyon 1
)
18 Jan 18
1:00 PM
-
5:00 PM
Optimizing Outcomes and Therapeutic Drug Monitoring
(
Room
Bristlecone 3
)
18 Jan 18
1:00 PM
-
2:00 PM
The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic and Translational Research Workshop
(
Room
Pinyon 3
)
18 Jan 18
1:00 PM
-
5:00 PM
Welcome and Introduction
(
Room
Pinyon 1
)
18 Jan 18
1:00 PM
-
1:10 PM
Welcome and Introduction
(
Room
Bristlecone 4
)
18 Jan 18
1:00 PM
-
1:05 PM
Can Diet Be Used to Treat Pediatric IBD?
(
Room
Bristlecone 4
)
18 Jan 18
1:05 PM
-
1:25 PM
Keynote: The Importance of Mentoring for an Academic IBD Career
(
Room
Pinyon 3
)
18 Jan 18
1:05 PM
-
1:30 PM
Regulatory Considerations for Microbiota Transplantation
(
Room
Bristlecone 2
)
18 Jan 18
1:05 PM
-
1:35 PM
Balancing Research and Scholarly Activities with Practice
(
Room
Pinyon 1
)
18 Jan 18
1:10 PM
-
1:40 PM
What’s Next? Moving Past Anti-TNFs for Pediatric IBD?
(
Room
Bristlecone 4
)
18 Jan 18
1:25 PM
-
1:45 PM
Sneak Peek into a Basic Grant Review Panel - Grant Proposal Presentation and Mock Study
(
Room
Pinyon 3
)
18 Jan 18
1:30 PM
-
2:10 PM
Debate: FMT is an Effective and Safe Therapeutic Intervention That Does Not Require Regulatory Oversight
(
Room
Bristlecone 2
)
18 Jan 18
1:35 PM
-
2:00 PM
Care of the Medically Complex Patient
(
Room
Pinyon 1
)
18 Jan 18
1:40 PM
-
2:10 PM
Translational Advances in Pediatric IBD — How Will It Affect My Practice?
(
Room
Bristlecone 4
)
18 Jan 18
1:45 PM
-
2:05 PM
FMT National Registry Rationale and Approach
(
Room
Bristlecone 2
)
18 Jan 18
2:00 PM
-
2:25 PM
Understanding Risks of IBD Therapies and Minimizing Risk
(
Room
Bristlecone 3
)
18 Jan 18
2:00 PM
-
3:00 PM
4 - CO-DELIVERY OF TNF-α SIRNA AND IL-22 VIA A NANOPARTICLE-IN-HYDROGEL SYSTEM EXERTS SYNERGISTIC THERAPEUTIC EFFECTS AGAINST ULCERATIVE COLITIS
(
Room
Pinyon 3
)
18 Jan 18
2:10 PM
-
2:25 PM
Insights on Patient Perspectives and Their Care
(
Room
Pinyon 1
)
18 Jan 18
2:10 PM
-
2:40 PM
5 - LOSS OF ESTROGEN RECEPTOR BETA IN A SPONTANEOUS MODEL OF CROHN'S-LIKE ILEITIS REVEALS SEX-SPECIFIC FUNCTIONS OF ESTROGEN SIGNALING AMONG INTESTINAL REGULATORY T CELLS
(
Room
Pinyon 3
)
18 Jan 18
2:25 PM
-
2:40 PM
Beyond FMT — Future of Microbiota-Based Therapies and Status of Current Industry-Sponsored Clinical Trials
(
Room
Bristlecone 2
)
18 Jan 18
2:25 PM
-
2:55 PM
1 - EFFECTIVENESS OF ORAL IRON SUPPLEMENTATION IN THE TREATMENT OF ANEMIA ASSOCIATED WITH PEDIATRIC ULCERATIVE COLITIS FLARE
(
Room
Bristlecone 4
)
18 Jan 18
2:30 PM
-
2:40 PM
2 - TREATMENT OF PEDIATRIC CROHN’S DISEASE PATIENTS WITH EARLY PERIANAL COMPLICATIONS
(
Room
Bristlecone 4
)
18 Jan 18
2:40 PM
-
2:50 PM
6 - MATRIX METALLOPROTEINASE MEDIATED CLEAVAGE OF SURFACE PD-L1 ON (MYO)FIBROBLAST CONTRIBUTES TO THE DYSREGULATION OF T-CELL RESPONSES IN CROHN’S DISEASE
(
Room
Pinyon 3
)
18 Jan 18
2:40 PM
-
2:55 PM
3 - ENDOSCOPIC AND HISTOLOGIC SCORES AS PREDICTORS OF PROGRESSION TO COLECTOMY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS
(
Room
Bristlecone 4
)
18 Jan 18
2:50 PM
-
3:00 PM
Coffee Break
(
Room
Pinyon 3
)
18 Jan 18
2:55 PM
-
3:05 PM
Physician Panel — Case Discussions and Question and Answer
(
Room
Bristlecone 3
)
18 Jan 18
3:00 PM
-
4:00 PM
7 - FRAGMENTED CARE IS PREVALENT AMONG IBD HOSPITALIZATIONS AND IS ASSOCIATED WITH WORSE OUTCOME
(
Room
Pinyon 3
)
18 Jan 18
3:05 PM
-
3:20 PM
IBD Self-Management: Assessment and Educational Tools
(
Room
Pinyon 1
)
18 Jan 18
3:10 PM
-
3:40 PM
Recent AGA Clinical Guidelines: Takeaways for Pediatric IBD Care
(
Room
Bristlecone 4
)
18 Jan 18
3:10 PM
-
3:35 PM
FMT for the Inflammatory Bowel Diseases: Ulcerative Colitis, Crohn’s Disease and Pouchitis
(
Room
Bristlecone 2
)
18 Jan 18
3:15 PM
-
3:45 PM
8 - TELEMEDICINE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE (TELE-IBD) DECREASES INFLAMMATORY BOWEL DISEASE (IBD)-RELATED HOSPITALIZATIONS
(
Room
Pinyon 3
)
18 Jan 18
3:20 PM
-
3:35 PM
9 - INFECTIOUS AND THROMBOTIC RISKS OF PARENTERAL NUTRITION IN HOSPITALIZED PEDIATRIC IBD PATIENTS
(
Room
Pinyon 3
)
18 Jan 18
3:35 PM
-
3:50 PM
Clinical Case Presentation 1: Adolescent /Young Adult Female With Severe Steroid-Resistant Crohn’s Colitis
(
Room
Bristlecone 4
)
18 Jan 18
3:35 PM
-
3:45 PM
Health Maintenance in Pediatrics and Beyond
(
Room
Pinyon 1
)
18 Jan 18
3:40 PM
-
4:10 PM
Clinical Case Presentation 2: Boy on Methotrexate with Hypoalbuminemia, Growth Failure Starting Anti-TNF — What Dose, Combination Therapy? Do I Check Levels?
(
Room
Bristlecone 4
)
18 Jan 18
3:45 PM
-
3:55 PM
FMT for rCDI and IBD in Pediatric Patients: Unique Considerations
(
Room
Bristlecone 2
)
18 Jan 18
3:45 PM
-
4:15 PM
Sneak Peek into a Clinical Grant Review Panel - Grant Proposal Presentation and Mock Study
(
Room
Pinyon 3
)
18 Jan 18
3:50 PM
-
4:35 PM
Breakouts for Case Discussions
(
Room
Bristlecone 4 or Starvine 4
)
18 Jan 18
3:55 PM
-
4:35 PM
Pregnancy and IBD
(
Room
Pinyon 1
)
18 Jan 18
4:10 PM
-
4:40 PM
FMT on the Horizon: Metabolic Syndrome and Other Diseases
(
Room
Bristlecone 2
)
18 Jan 18
4:15 PM
-
4:45 PM
Case Discussion Debrief
(
Room
Bristlecone 4
)
18 Jan 18
4:35 PM
-
5:00 PM
Keynote: How to Be an Entrepreneur in Biomedical Science
(
Room
Pinyon 3
)
18 Jan 18
4:35 PM
-
5:00 PM
Questions and Wrap-Up
(
Room
Pinyon 1
)
18 Jan 18
4:40 PM
-
5:00 PM
Closing Remarks
(
Room
Pinyon 3
)
18 Jan 18
5:00 PM
-
5:05 PM
Satellite Symposium: From Promise to Practice: Therapies Offering High Hopes in Meeting IBD Therapeutic Endpoints
(
Room
Pinyon 5
)
18 Jan 18
5:30 PM
-
7:30 PM
Satellite Symposium: Putting Patients First: Digital Health Tools to Empower IBD Patients
(
Room
Pinyon 7/8
)
18 Jan 18
5:30 PM
-
7:30 PM
Satellite Symposium: Fact or Fiction? Sorting Out Common Misconceptions About UC to Improve Patient Care
(
Room
Pinyon 7/8
)
19 Jan 18
6:00 AM
-
7:30 AM
Welcome
(
Room
Pinyon 4/5
)
19 Jan 18
7:45 AM
-
7:55 AM
Welcome & Opening Panel
(
Room
Pinyon 4/5
)
19 Jan 18
7:45 AM
-
8:20 AM
Concept and Findings of the Foundation’s Update to “Challenges in IBD”
(
Room
Pinyon 4/5
)
19 Jan 18
7:54 AM
-
8:20 AM
Keynote Research Presentation: Is Complicated IBD Genetically Defined?
(
Room
Pinyon 4/5
)
19 Jan 18
8:25 AM
-
8:45 AM
Keynote Clinical Presentation: Non-Responders to Current Biologics: What Treatments Are on the Horizon?
(
Room
Pinyon 4/5
)
19 Jan 18
8:45 AM
-
9:05 AM
10 - EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIED SHARED METHYLOMIC CONTRIBUTIONS TO SUSCEPTIBILITY AND PROGRESSION IN PEDIATRIC CROHN'S DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
9:05 AM
-
9:15 AM
11 - DELAYED ILEAL POUCH ANAL ANASTOMOSIS HAS A LOWER 30-DAY ADVERSE EVENT RATE: ANALYSIS FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM
(
Room
Pinyon 4/5
)
19 Jan 18
9:15 AM
-
9:25 AM
12 - HIGH PATIENT ACTIVATION IS ASSOCIATED WITH CLINICAL REMISSION IN A LONGITUDINAL ANALYSIS OF A LARGE INTERNET BASED COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
9:25 AM
-
9:35 AM
Poster Presentations
19 Jan 18
10:00 AM
-
10:30 AM
Adolescent, Young Adults and Pregnant Patients with IBD
(
Room
Pinyon 3
)
19 Jan 18
10:30 AM
-
11:30 AM
Management of Perianal and Pouch Complications
(
Room
Bristlecone 3
)
19 Jan 18
10:30 AM
-
11:30 AM
The Multidisciplinary Care of the Complicated IBD Patient
(
Room
Pinyon 4/5
)
19 Jan 18
10:30 AM
-
11:30 AM
Adolescent, Young Adults and Pregnant Patients with IBD (repeated)
(
Room
Pinyon 3
)
19 Jan 18
11:30 AM
-
12:20 PM
Management of Perianal and Pouch Complications (repeated)
(
Room
Bristlecone 3
)
19 Jan 18
11:30 AM
-
12:20 PM
The Multidisciplinary Care of the Complicated IBD Patient (repeated)
(
Room
Pinyon 4/5
)
19 Jan 18
11:30 AM
-
12:20 PM
Satellite Symposium: IBD Nutrition Assessment, Intervention and Treatment
(
Room
Pinyon 1/2
)
19 Jan 18
12:35 PM
-
1:40 PM
Satellite Symposium: Vaccinations and IBD: Special Considerations and Preventive Measures to Improve Patient Outcomes
(
Room
Pinyon 7/8
)
19 Jan 18
12:35 PM
-
1:40 PM
Keynote Clinical Presentation: How to Incorporate New Therapies into Current Practice
(
Room
Pinyon 4/5
)
19 Jan 18
2:00 PM
-
2:20 PM
13 - REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
2:20 PM
-
2:30 PM
Keynote Research Presentation: Biomarkers for Precision Medicine
(
Room
Pinyon 4/5
)
19 Jan 18
2:30 PM
-
2:50 PM
14 - POST-HOC ANALYSIS OF TOFACITINIB CROHN’S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION
(
Room
Pinyon 4/5
)
19 Jan 18
2:50 PM
-
3:00 PM
Multidisciplinary Panel Review of Cases
(
Room
Pinyon 4/5
)
19 Jan 18
3:20 PM
-
4:10 PM
Poster Presentations
19 Jan 18
4:10 PM
-
4:40 PM
Challenges in Monitoring Response
(
Room
Pinyon 4/5
)
19 Jan 18
4:40 PM
-
5:20 PM
Predictors of Immune Response: How to Decide Which Therapy to Choose
(
Room
Pinyon 3
)
19 Jan 18
4:40 PM
-
4:55 PM
Proactive Therapeutic Drug Monitoring — For Whom and How
(
Room
Pinyon 4/5
)
19 Jan 18
4:40 PM
-
4:55 PM
Research That Will Guide Your Practice, Not Tomorrow, But Soon
(
Room
Pinyon 3
)
19 Jan 18
4:40 PM
-
5:20 PM
Asymptomatic but Ongoing Inflammation — What Now and Does Age Matter?
(
Room
Pinyon 4/5
)
19 Jan 18
4:55 PM
-
5:10 PM
Fecal Metabolomic Analysis: Ready for Clinical Use?
(
Room
Pinyon 3
)
19 Jan 18
4:55 PM
-
5:10 PM
P001 - #IBD: A WORD ASSOCIATION ANALYSIS OF TWEETS ABOUT INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P002 - 2-ACCETYL-4-TETRAHYDROXYBUTYL IMIDAZOLE AMELIORATES DEXTRAN SULFATE SODIUM-INDUCED COLITIS VIA SUPPRESSION OF SPHINGOSINE-1-PHOSPHATE LYASE
19 Jan 18
5:30 PM
-
7:00 PM
P003 - A COMPARISON OF THE MUCOSA-ASSOCIATED MICROBIAL COMMUNITY STRUCTURE BETWEEN INFLAMED AND NON-INFLAMED SITES IN PATIENTS WITH ULCERATIVE COLITIS
19 Jan 18
5:30 PM
-
7:00 PM
P004 - A DIET LOW IN RED AND PROCESSED MEATS DOES NOT REDUCE THE RATE OF CROHN’S DISEASE FLARES IN A RANDOMIZED CONTROLLED TRIAL: RESULTS OF THE FOOD AND CROHN’S DISEASE EXACERBATION STUDY (FACES)
19 Jan 18
5:30 PM
-
7:00 PM
P005 - A MUCOSAL AND CHEMOKINE LIGAND FOR THE LYMPHOCYTE CHEMOATTRACTANT RECEPTOR GPR15
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
Page
1
of
4
Home
Sessions
Speakers
Exhibitors
Floor Plan
Tweet
Login
|
Back to top
ChirpE